STOCK TITAN

Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference

Nautilus Biotechnology (NASDAQ: NAUT) will participate in the TD Cowen 46th Annual Health Care Conference.

(Neutral)
(Neutral)
Tags

Nautilus Biotechnology (NASDAQ: NAUT) will participate in the TD Cowen 46th Annual Health Care Conference. Management is scheduled for a fireside chat on March 2, 2026 at 10:30 a.m. ET. A live and archived webcast will be available on the company Investors website at www.nautilus.bio.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.
Argus Feb 20 session
-2.42% close to close Open Argus
Details

News Market Reaction – NAUT

In the Feb 20 session, NAUT declined 2.42%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights Nautilus’ upcoming fireside chat at a major health care conference on M...
Analysis

This announcement highlights Nautilus’ upcoming fireside chat at a major health care conference on March 2, 2026, which can increase visibility for its single-molecule proteomics platform. In recent months, the company reported progress toward early access and a broader commercial launch in 2026, alongside collaborations in neurodegenerative and Parkinson’s research. Investors may track how management discusses timelines, cash runway from prior filings, and adoption of early access programs during the conference presentation.

Key Figures

Conference edition: 46th annual Presentation date: March 2, 2026 Presentation time: 10:30 a.m. Eastern Time
Conference edition
46th annual
TD Cowen Health Care Conference
Presentation date
March 2, 2026
Fireside chat schedule
Presentation time
10:30 a.m. Eastern Time
TD Cowen fireside chat

Historical Context

5 past events · Latest: Feb 05
5 events
  1. Feb 05

    Earnings date notice

    24h Move
    -2.9%

    Announced timing of Q4 and full-year 2025 results and webcast details.

  2. Jan 28

    Research partnership

    24h Move
    -7.6%

    MJFF-supported collaboration on Parkinson’s single-molecule proteomics assay.

  3. Jan 08

    Platform early access

    24h Move
    +0.0%

    Launched early access program focused on tau proteoforms assay for researchers.

  4. Nov 03

    Field unit validation

    24h Move
    +39.1%

    Reported first external field evaluation unit with reproducible multi-site data.

  5. Oct 28

    Q3 2025 earnings

    24h Move
    +5.9%

    Lower operating expenses, narrower loss, and strong cash balance disclosure.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

webcast
1 terms
webcast technical
"Interested parties may access a live and archived webcast of the presentation"
A webcast is a live or recorded online event where people watch or listen to presentations, announcements, or performances through the internet. It’s like a TV broadcast but over the internet, allowing viewers from anywhere to tune in in real time or later. Webcasts are important because they let companies share information quickly and widely with audiences around the world.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

SEATTLE, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the TD Cowen 46th Annual Health Care Conference.

Nautilus’ management is scheduled to participate in a fireside chat on Monday, March 2, 2026, at 10:30 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.nautilus.bio.

About Nautilus Biotechnology, Inc.
With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio.

Media Contact
press@nautilus.bio

Investor Contact
investorrelations@nautilus.bio


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Nautilus Biotechnology (NAUT) present at the TD Cowen 46th Annual Health Care Conference?

Nautilus management will present in a fireside chat on March 2, 2026 at 10:30 a.m. ET. According to the company, the session is part of the TD Cowen 46th Annual Health Care Conference and is open via webcast for investors and interested parties.

How can investors watch Nautilus Biotechnology's (NAUT) presentation at the TD Cowen conference?

Investors can access a live and archived webcast on the company's Investors website at www.nautilus.bio. According to the company, the webcast will be available live on March 2, 2026 and archived afterwards for on-demand viewing.

What is the scheduled format for Nautilus Biotechnology's (NAUT) participation at the TD Cowen event?

Nautilus is scheduled for a fireside chat format during the conference on March 2, 2026 at 10:30 a.m. ET. According to the company, management will discuss company developments and answer questions in that moderated format.

Will Nautilus Biotechnology (NAUT) provide an archived recording of its TD Cowen presentation?

Yes, an archived webcast will be available on the company's Investors website after the live session. According to the company, the archived recording will allow investors to review the March 2, 2026 fireside chat on demand.

Why is Nautilus Biotechnology (NAUT) participating in the TD Cowen 46th Annual Health Care Conference?

The company is participating to present management perspectives and company updates to investors and analysts. According to the company, the March 2, 2026 fireside chat provides a platform to communicate its single-molecule protein analysis progress and strategic priorities.

Keep reading